Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  DNA Repair

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.dnarep.2008.09.003PMID 18840549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploring the roles of Mus81-Eme1/Mms4 at perturbed replication forks.

  2007cited by this paper
• Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2

  2007cited by this paper
• MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

  2007cited by this paper
• Non-homologous end-joining, a sticky affair.

  2007cited by this paper
• Non-homologous end-joining, a sticky affair

  2007cited by this paper
• DNA double-strand break repair: from mechanistic understanding to cancer treatment.

  2007cited by this paper
• Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

  2007cited by this paper
• Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA.

  2007cited by this paper
• Homologous recombination prevents methylation-induced toxicity in Escherichia coli

  2006cited by this paper
• ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.

  2006cited by this paper
• Xrcc2 deficiency sensitizes cells to apoptosis by MNNG and the alkylating anticancer drugs temozolomide, fotemustine and mafosfamide.

  2006cited by this paper
• ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine Adducts

  2006cited by this paper
• Human MutScv recognizes damaged DNA base pairs containing 06-methylguanine, 04-methylthymine, or the cisplatin-d(GpG) adduct

  2005cited by this paper
• Homologous recombination rescues mismatch-repair-dependent cytotoxicity of S(N)1-type methylating agents in S. cerevisiae.

  2005cited by this paper
• Double Strand Break Repair by Homologous Recombination Is Regulated by Cell Cycle-independent Signaling via ATM in Human Glioma Cells*

  2004cited by this paper
• Homologous recombination-mediated double-strand break repair.

  2004cited by this paper
• MGMT: its role in cancer aetiology and cancer therapeutics

  2004cited by this paper
• Mechanisms and consequences of methylating agent-induced SCEs and chromosomal aberrations: a long road traveled and still a far way to go

  2004cited by this paper
• Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.

  2004cited by this paper
• DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.

  2004cited by this paper
• Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/Apo-1

  2004cited by this paper
• hXRCC2 Enhances ADP/ATP Processing and Strand Exchange by hRAD51*

  2004cited by this paper
• Loss of ATM sensitizes against O6-methylguanine triggered apoptosis, SCEs and chromosomal aberrations.

  2004cited by this paper
• Variability and regulation of O6-alkylguanine-DNA alkyltransferase.

  2003cited by this paper
• Brca2 (XRCC11) Deficiency Results in Radioresistant DNA Synthesis and a Higher Frequency of Spontaneous Deletions

  2002cited by this paper
• Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine.

  2002cited by this paper
• End-joining deficiency and radiosensitization induced by gemcitabine.

  2001cited by this paper
• Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

  2001cited by this paper
• Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.

  2000cited by this paper
• Determination of the initial DNA damage and residual DNA damage remaining after 12 hours of repair in eleven cell lines at low doses of irradiation.

  2000cited by this paper
• Repair of O(6)-alkylguanine by alkyltransferases.

  2000cited by this paper
• DNA double-strand break repair in cell-free extracts from Ku80-deficient cells: implications for Ku serving as an alignment factor in non-homologous DNA end joining

  2000cited by this paper
• Repair of O6-alkylguanine by alkyltransferases

  2000cited by this paper
• Mismatch repair is required for O(6)-methylguanine-induced homologous recombination in human fibroblasts.

  2000cited by this paper
• Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2

  1999cited by this paper
• Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination

  1999cited by this paper
• Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.

  1999cited by this paper
• Involvement of the mismatch repair system in temozolomide-induced apoptosis.

  1998cited by this paper
• XR-C1, a new CHO cell mutant which is defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint formation

  1998cited by this paper
• O6-alkylguanine DNA lesions trigger apoptosis.

  1998cited by this paper
• Double Strand Break Repair*

  1997cited by this paper
• Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting.

  1997cited by this paper
• Chromosomal instability, reproductive cell death and apoptosis induced by O6-methylguanine in Mex-, Mex+ and methylation-tolerant mismatch repair compromised cells: facts and models.

  1997cited by this paper
• Double strand break repair.

  1997cited by this paper
• Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants

  1996cited by this paper
• Localization to chromosome 7q36.1 of the human XRCC2 gene, determining sensitivity to DNA-damaging agents.

  1995cited by this paper
• O6‐methylguanine‐DNA methyltransferase activity in breast and brain tumors

  1995cited by this paper
• Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.

  1995cited by this paper
• DNA damage tolerance, mismatch repair and genome instability

  1994cited by this paper
• NMR and molecular modeling investigation of the mechanism of activation of the antitumor drug temozolomide and its interaction with DNA.

  1994cited by this paper
• On the quantitative relationship between O6-methylguanine residues in genomic DNA and production of sister-chromatid exchanges, mutations and lethal events in a Mer- human tumor cell line.

  1994cited by this paper
• Contribution of O6‐alkylguanine and N‐alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell lines

  1993cited by this paper
• The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

  1993cited by this paper
• Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage

  1993cited by this paper
• Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

  1992cited by this paper
• Transfection and expression of human O6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: the role of MGMT in protection against the genotoxic effects of alkylating agents.

  1991cited by this paper
• Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents.

  1990cited by this paper
• Expression of the E.coli ada gene in yeast protects against the toxic and mutagenic effects of N-methyl-N'-nitro-N-nitrosoguanidine.

  1990cited by this paper
• Cancer Chemotherapy: Principles and Practice

  1990cited by this paper
• Cytological characterization of Chinese hamster ovary X-ray-sensitive mutant cells xrs 5 and xrs 6. I. Induction of chromosomal aberrations by X-irradiation and its modulation with 3-aminobenzamide and caffeine.

  1987cited by this paper
• Dependency of the yield of sister-chromatid exchanges induced by alkylating agents on fixation time. Possible involvement of secondary lesions in sister-chromatid exchange induction.

  1985cited by this paper
• Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains

  1980cited by this paper
• Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure.

  1979cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• The occurrence and determination of N-nitroso compounds.

  1975cited by this paper
• New Giemsa method for the differential staining of sister chromatids

  1974cited by this paper

• Temozolomide‐Promoted MGMT Transcription Contributes to Chemoresistance by Activating the ERK Signalling Pathway in Malignant Melanoma

  2025cites this paper
• Senotherapeutics in Malignant Brain Cancer Therapy

  2025cites this paper
• DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology.

  2024cites this paper
• Targeting DNA Repair Pathways in Orthotopic Glioblastoma Xenoplants

  2024cites this paper
• ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma

  2024influential citation
• Helicobacter pylori plus N-Methyl-N'-nitro-N-nitrosoguanidine: DNA damage and repair: Malignant transformation of human esophageal epithelial cells.

  2023cites this paper
• DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways

  2023cites this paper
• Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?

  2023cites this paper
• Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumors.

  2022cites this paper
• Dose response to methylating agents in the γH2AX, SCE and colony formation assays: Effect of MGMT and MPG overexpression.

  2022cites this paper
• Chk1/2 inhibitor AZD7762 enhances the susceptibility of IDH-mutant brain cancer cells to temozolomide

  2022cites this paper
• Temozolomide – Just a Radiosensitizer?

  2022cites this paper
• The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies

  2022cites this paper
• Class I HDAC overexpression promotes temozolomide resistance in glioma cells by regulating RAD18 expression

  2022cites this paper
• Identifying gene expression patterns associated with drug-specific survival in cancer patients

  2021cites this paper
• ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide

  2021cites this paper
• Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination

  2021cites this paper
• SLX4 dampens MutSα-dependent mismatch repair

  2021cites this paper
• Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.

  2021cites this paper
• Comprehensive pharmacogenomics characterization of temozolomide response in gliomas.

  2021cites this paper
• Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells

  2021cites this paper
• XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase

  2021cites this paper
• Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas

  2021cites this paper
• Búsqueda de nuevos biomarcadores genéticos en gliomas de alto grado

  2020cites this paper
• Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications

  2020cites this paper
• Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma

  2020cites this paper
• Disruption of mstna and mstnb gene through CRISPR/Cas9 leads to elevated muscle mass in blunt snout bream (Megalobrama amblycephala)

  2020cites this paper
• Critical appraisal of MGMT in digestive NET treated with alkylating agents.

  2020cites this paper
• The role of the redox/miR-6855-3p/PRDX5A axis in reversing SLUG-mediated BRCA2 silencing in breast cancer cells

  2020cites this paper
• XAB2 prevents abortive recombinational repair of replication-associated DNA double-strand breaks and its loss is synthetic lethal with RAD52 inhibition

  2020cites this paper
• Vemurafenib Sensitizes Melanoma Cells to Temozolomide by Downregulating MGMT Expression.

  2020cites this paper
• Biological Basis for Threshold Responses to Methylating Agents

  2020cites this paper
• DNA Double Strand Break Repair - Related Synthetic Lethality.

  2019cites this paper
• XRCC2 (X-ray repair cross complementing 2)

  2019cites this paper
• DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas.

  2019cites this paper
• XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair.

  2018cites this paper
• Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51

  2018cites this paper
• Downregulation of IGF1R Expression Inhibits Growth and Enhances Cisplatin Sensitivity of Head and Neck Squamous Cell Carcinoma Cells In Vitro

  2018cites this paper
• Exceptional Response to Dacarbazine in Uterine Leiomyosarcoma With Homozygous BRCA2 Deletion Highlights the Role of Homologous Recombination in Response to DNA Damage From Alkylating Agents.

  2018cites this paper
• Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling.

  2017cites this paper
• Exploiting Genetic Vulnerabilities to Overcome Treatment Resistance in Adult Gliomas

  2017cites this paper
• Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

  2017cites this paper
• PLK1 inhibition enhances temozolomide efficacy in IDH1 mutant gliomas

  2017cites this paper
• The Brassica-derived phytochemical indolo[3,2-b]carbazole protects against oxidative DNA damage by aryl hydrocarbon receptor activation

  2017cites this paper
• Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma

  2017cites this paper
• MGMT—a critical DNA repair gene target for chemotherapy resistance

  2016cites this paper
• Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence

  2016cites this paper
• Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.

  2016cites this paper
• Poor recognition of O6-isopropyl dG by MGMT triggers double strand break-mediated cell death and micronucleus induction in FANC-deficient cells

  2016cites this paper
• Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs

  2016cites this paper
• Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins.

  2016cites this paper
• PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas

  2016cites this paper
• Prolonged Ezh2 Depletion in Glioblastoma Causes a Robust Switch in Cell Fate Resulting in Tumor Progression.

  2015cites this paper
• Theoretical considerations for thresholds in chemical carcinogenesis.

  2015cites this paper
• Nuclear‐Targeting MSNs‐Based Drug Delivery System: Global Gene Expression Analysis on the MDR‐Overcoming Mechanisms

  2015cites this paper
• IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide

  2015cites this paper
• Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction.

  2015cites this paper
• Exploring New Strategies to Overcome Resistance in Glioblastoma Multiforme: A Dissertation

  2015cites this paper
• Mecanismos de reparo de DNA envolvidos com lesões induzidas por agente alquilante (Nimustina) em células humanas e sua associação com a resistência de gliomas.

  2014cites this paper
• Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair

  2014cites this paper
• Biochemical and Cellular Studies of Human MSH2 ATPase Domain Mutants Support the Molecular Switch Model of Mismatch Repair In Vivo

  2014cites this paper
• Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy - a review.

  2014cites this paper
• Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide

  2014cites this paper
• Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance.

  2014cites this paper
• Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities.

  2013cites this paper
• Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy with Cetuximab, Temozolomide, and Radiation

  2013cites this paper
• Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage

  2013cites this paper
• Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling

  2013cites this paper
• DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis.

  2013cites this paper
• O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer.

  2013cites this paper
• Human O6‐methylguanine‐DNA methyltransferase containing C145A does not prevent hepatocellular carcinoma in C3HeB/FeJ transgenic mice

  2013cites this paper
• O6-Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling network activation.

  2012cites this paper
• Defective DNA Mismatch Repair-dependent c-Abl-p73-GADD45α Expression Confers Cancer Chemoresistance

  2012cites this paper
• Balancing repair and tolerance of DNA damage caused by alkylating agents

  2012cites this paper
• Human Monocytes Undergo Excessive Apoptosis following Temozolomide Activating the ATM/ATR Pathway While Dendritic Cells and Macrophages Are Resistant

  2012cites this paper
• Chloroethylnitrosourea-induced cell death and genotoxicity: Cell cycle dependence and the role of DNA double-strand breaks, HR and NHEJ

  2012cites this paper
• Pol kappa partially rescues MMR-dependent cytotoxicity of O6-methylguanine.

  2012cites this paper
• Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells.

  2012cites this paper
• Targeting Homologous Recombination Repair in Cancer

  2012cites this paper
• Synergistic cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine and absence of poly(ADP-ribose) glycohydrolase involves chromatin decondensation.

  2011cites this paper
• FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ

  2011cites this paper
• DNA Damage and Cellular Stress Responses The Homologous Recombination Protein RAD 51 D Mediates the Processing of 6-Thioguanine Lesions Downstream of Mismatch Repair

  2011cites this paper
• Repair pathways independent of the Fanconi anemia nuclear core complex play a predominant role in mitigating formaldehyde-induced DNA damage.

  2011cites this paper
• Correction: FANCD1/BRCA2 Plays Predominant Role in the Repair of DNA Damage Induced by ACNU or TMZ

  2011cites this paper
• Cell-based phenotypic screens to identify modulators of sensitivity to N-methyl-N'-nitro-N-nitrosoguanidine

  2011cites this paper
• Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs

  2011cites this paper
• The Homologous Recombination Protein RAD51D Mediates the Processing of 6-Thioguanine Lesions Downstream of Mismatch Repair

  2011cites this paper
• Essential Roles of BCCIP in Mouse Embryonic Development and Structural Stability of Chromosomes

  2011cites this paper
• Comparison of Proliferation and Genomic Instability Responses to WRN Silencing in Hematopoietic HL60 and TK6 Cells

  2011cites this paper
• Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.

  2011cites this paper
• Intrinsic anticancer drug resistance of malignant melanoma cells is abrogated by IFN-β and valproic acid.

  2011cites this paper
• A role for XRCC2 gene polymorphisms in breast cancer risk and survival

  2011cites this paper
• DNA Damage Induced by Alkylating Agents and Repair Pathways

  2010cites this paper
• 6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.

  2010cites this paper
• Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles

  2010cites this paper
• MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome

  2010cites this paper
• Homologous recombination protects mammalian cells from replication-associated DNA double-strand breaks arising in response to methyl methanesulfonate.

  2010cites this paper
• RAD51D protects against MLH1-dependent cytotoxic responses to O(6)-methylguanine.

  2010cites this paper
• Nijmegen Breakage Syndrome Protein (NBN) Causes Resistance to Methylating Anticancer Drugs Such as Temozolomide

  2010cites this paper
• Therapeutics , Targets , and Chemical Biology Cancer Research 6-Thioguanine Selectively Kills BRCA 2-Defective Tumors and Overcomes PARP Inhibitor Resistance

  2010cites this paper